$BMY U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma....
https://www.stocktitan.net/news/BMY/u-s-food-and-drug-administration-approves-opdivo-r-nivolumab-in-7okuwzx5u710.html

#cancer
<ticker> u . s . food and drug administration approves opdivo ® nivolumab in combination with chemotherapy for patients with advanced or metastatic gastric cancer , gastroesophageal junction cancer , and esophageal adenocarcinoma . . cancer